Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285797
Max Phase: Preclinical
Molecular Formula: C24H11BrN2O4S
Molecular Weight: 503.33
Associated Items:
ID: ALA5285797
Max Phase: Preclinical
Molecular Formula: C24H11BrN2O4S
Molecular Weight: 503.33
Associated Items:
Canonical SMILES: O=C1c2cccc3cccc(c23)C(=O)N1c1nc(-c2cc3cc(Br)ccc3oc2=O)cs1
Standard InChI: InChI=1S/C24H11BrN2O4S/c25-14-7-8-19-13(9-14)10-17(23(30)31-19)18-11-32-24(26-18)27-21(28)15-5-1-3-12-4-2-6-16(20(12)15)22(27)29/h1-11H
Standard InChI Key: NFMUVJRPOKFHIE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 503.33 | Molecular Weight (Monoisotopic): 501.9623 | AlogP: 5.63 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.48 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.54 | CX LogD: 5.54 |
Aromatic Rings: 5 | Heavy Atoms: 32 | QED Weighted: 0.23 | Np Likeness Score: -0.99 |
1. Tomczyk MD, Walczak KZ.. (2018) l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017., 159 [PMID:30312931] [10.1016/j.ejmech.2018.09.055] |
Source(1):